CONMED Corporation (CNMD)

Market Cap	1.82B
Revenue (ttm)	1.31B
Net Income (ttm)	132.42M
Shares Out	30.91M
EPS (ttm)	4.25
PE Ratio	13.84
Forward PE	13.56
Dividend	$0.80 (1.36%)
Ex-Dividend Date	Mar 14, 2025

Volume	378,895
Open	59.50
Previous Close	59.85
Day's Range	58.28 - 59.70
52-Week Range	55.22 - 80.65
Beta	1.54
Analysts	Buy
Price Target	77.20 (+31.18%)
Earnings Date	Apr 23, 2025

About CNMD

CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform mini...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jul 23, 1987
• Employees: 3,900
• Stock Exchange: NYSE
• Ticker Symbol: CNMD
• Website: https://www.conmed.com

Financial Performance

In 2024, CONMED's revenue was $1.31 billion, an increase of 5.00% compared to the previous year's $1.24 billion. Earnings were $132.42 million, an increase of 105.44%.

Analyst Forecast

According to 5 analysts, the average rating for CNMD stock is "Buy." The 12-month stock price forecast is $77.2, which is an increase of 31.18% from the latest price.

Price Target

$77.2

(31.18% upside)

Analyst Consensus: Buy